Back to Search Start Over

Drug use practices and wound care experiences in the age of xylazine adulteration.

Authors :
Jawa, Raagini
Ismail, Samia
Shang, Margaret
Murray, Stephen
Murray-Krezan, Cristina
Zheng, Yihao
Mackin, Sarah
Washington, Kenny
Alvarez, Pedro
Dillon, Jaime
McMurtrie, Gary
Stein, Michael
Walley, Alexander
Liebschutz, Jane M.
Source :
Drug & Alcohol Dependence. Oct2024, Vol. 263, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

Exposure to xylazine has been associated with wounds distinct from typical injection-related skin and soft tissue infections. We sought to understand drug use and wound care practices, and treatment experiences of people who use drugs (PWUD) in a high-prevalence area of xylazine adulteration. In August 2023, we surveyed adult PWUD reporting at least one past-year drug use-related wound across three Massachusetts syringe service programs. Using a representative illustration, participants indicated if they had experienced a xylazine wound in the past 90 days. We compared demographic, drug use factors, wound care, and medical treatment experiences among those with and without xylazine wounds. We also conducted additional content analysis of open-ended responses. Of the 171 respondents, 87 % (n=148) had a xylazine wound in the past 90 days. There were no statistically significant demographic differences between those with and without xylazine wounds. Among those primarily injecting (n=155), subcutaneous injection was nearly ten times more likely among people with xylazine wounds. For those with xylazine wounds (n=148), many engaged in heterogeneous wound self-treatment practices, and when seeking medical care, 74 % experienced healthcare stigma and 58 % had inadequate pain and withdrawal management. People with self-identified xylazine wounds were more likely to engage in subcutaneous injection and faced several barriers seeking medical wound treatment. Programs serving people exposed to xylazine should work to support safer injection practices, including alternatives to injecting and improving access to high-quality, effective wound care. Further study is warranted to understand the causes, promoters, and prevention of xylazine-related wounds. [Display omitted] • Subcutaneous injection was more common among those reporting past 90-day xylazine wounds. • Those with xylazine wounds frequently engaged in heterogeneous wound self-treatment practices. • Many had negative experiences of stigma, inadequate pain and withdrawal management when seeking medical care for their wounds. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03768716
Volume :
263
Database :
Academic Search Index
Journal :
Drug & Alcohol Dependence
Publication Type :
Academic Journal
Accession number :
179499856
Full Text :
https://doi.org/10.1016/j.drugalcdep.2024.112390